A newly developed material forms a short-lived coating inside the stomach and intestine that blocks glucose absorption. Learn more about the ‘surgery in a pill.’
The 2016 European Society of Cardiology’s updated guidelines recommend everyone with Type 1 diabetes (T1D) initiate lipid-lowering agents at age 40, but that lipid-lowering agents be initiated at younger ages if there is evidence of nephropathy or with multiple risk factors present. This leads to the question: When does CV risk begin in T1D? Does CV risk actually begin at age 40, or are there people for whom this risk begins much earlier or even much later?